Informações:
Falhas:
ID
34308
Descrição
Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01598740
Link
https://clinicaltrials.gov/show/NCT01598740
Palavras-chave
Versões (1)
- 16/01/2019 16/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
16 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Heart Failure NCT01598740
Eligibility Heart Failure NCT01598740
- StudyEvent: Eligibility
Similar models
Eligibility Heart Failure NCT01598740
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
heart failure with new york heart association (nyha) classification ii or iii
boolean
ID.2
Item
chronic kidney disease
boolean
ID.3
Item
cardiac ejection fraction <40%
boolean
ID.4
Item
on heart failure therapy including an acei or arb, and a bb
boolean
ID.5
Item
willing to understand and comply with study procedures and provide written informed consent.
boolean
ID.6
Item
hospitalization within 4 weeks of baseline visit
boolean
ID.7
Item
history or presence of gastrointestinal conditions such as severe constipation or gastrointestinal tract strictures
boolean
ID.8
Item
current or anticipated dialysis during study
boolean
ID.9
Item
in the investigator's judgment, any cardiovascular, renal, hepatic, endocrine, gastrointestinal, neurological, or other disease or condition that makes the subject's study participation unsafe
boolean
ID.10
Item
drug or alcohol abuse
boolean